English
Select your country and region
English

Biocompatible Clear MED610

Rapidly produce medical and dental models and devices with Biocompatible Clear MED610 material
MED 610 is a transparent, biocompatible PolyJet™ material, approved for bodily contact. The material is designed to provide greater efficiency and more cost-effective productivity across a range of medical and dental applications.
The material creates rigid, transparent parts ideally for medical and dental applications requiring precise visualisation and patient contact.
Biocompatible Clear MED610 is suitable for permanent (more than 30 days) contact with intact skin, limited (up to 24 hours) contact with mucosal membranes and breached or compromised surfaces, and limited (up to 24 hours) contact with tissue and bone . The material is also suitable as a component in external communicating gas pathway devices . Printed parts with Biocompatible Clear can be sterilised with EtO, Steam, or Gamma sterilization methods.
Performance Properties:
  • check Izod Notched Impact: 20-30 J/m
  • check HDT @ 0.45MPa: 45-50 °C
  • check Flexural Strength: 75-110 Mpa
  • check Tensile Strength: 50-65 MPa

For more information regarding Biocompatibility requirements, Approved sterilization processes, Safety Guidelines and datasheets, please visit our support center webpage or contact us.

WARNING: This product can expose you to chemicals including , Toluene, which is known to the State of California to cause reproductive harm.  For more information go to www.P65Warnings.ca.gov.

[1] Evaluated according to biological testing under the procedures and provisions of EN ISO 10993-1:2018 “Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process” and FDA Guidance "Use of International Standard ISO 10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing within a Risk Management Process", dated 16 June 2016.  

[1] Evaluated according to EN ISO 18562-1:2017 “Biocompatibility evaluation of breathing gas pathways in healthcare applications” - Part 1: Evaluation and testing within a risk management process.